192 related articles for article (PubMed ID: 19631410)
1. [Prevalence and characteristics of anemia in inflammatory bowel disease].
de la Morena López F; Gisbert JP
Gastroenterol Hepatol; 2009 Nov; 32(9):591-9. PubMed ID: 19631410
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
3. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
[TBL] [Abstract][Full Text] [Related]
4. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial.
de Silva AD; Tsironi E; Feakins RM; Rampton DS
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1097-105. PubMed ID: 16305723
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia.
Bager P; Befrits R; Wikman O; Lindgren S; Moum B; Hjortswang H; Dahlerup JF
Scand J Gastroenterol; 2011 Mar; 46(3):304-9. PubMed ID: 21073374
[TBL] [Abstract][Full Text] [Related]
7. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
Gupta G; Gelfand JM; Lewis JD
Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of inflammatory bowel disease in patients with airways disease.
Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
[TBL] [Abstract][Full Text] [Related]
9. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
10. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
11. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
12. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency.
Minderhoud IM; Oldenburg B; van Dam PS; van Berge Henegouwen GP
Am J Gastroenterol; 2003 May; 98(5):1088-93. PubMed ID: 12809832
[TBL] [Abstract][Full Text] [Related]
15. Is there an association between coeliac disease and inflammatory bowel diseases? A study of relative prevalence in comparison with population controls.
Leeds JS; Höroldt BS; Sidhu R; Hopper AD; Robinson K; Toulson B; Dixon L; Lobo AJ; McAlindon ME; Hurlstone DP; Sanders DS
Scand J Gastroenterol; 2007 Oct; 42(10):1214-20. PubMed ID: 17918008
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation of inflammatory bowel disease: a hospital based retrospective study of 379 patients in eastern China.
Cao Q; Si JM; Gao M; Zhou G; Hu WL; Li JH
Chin Med J (Engl); 2005 May; 118(9):747-52. PubMed ID: 15899137
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of spondyloarthropathy in Puerto Rican patients with inflammatory bowel disease.
Rodriguez VE; Costas PJ; Vazquez M; Alvarez G; Perez-Kraft G; Climent C; Nazario CM
Ethn Dis; 2008; 18(2 Suppl 2):S2-225-9. PubMed ID: 18646354
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice.
Khalil A; Goodhand JR; Wahed M; Yeung J; Ali FR; Rampton DS
Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1029-35. PubMed ID: 21857526
[TBL] [Abstract][Full Text] [Related]
20. Chronic sinonasal disease in patients with inflammatory bowel disease.
Book DT; Smith TL; McNamar JP; Saeian K; Binion DG; Toohill RJ
Am J Rhinol; 2003; 17(2):87-90. PubMed ID: 12751702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
